Cardiac involvement in myotonic dystrophy: A nationwide cohort study

European Heart Journal

Volumn 35, Issue 32, 2014, Pages 2158-2164

  Lund, Marie ^a   Diaz, Lars Jorge ^a   Ranthe, Mattis Flyvholm ^a   Petri, Helle ^b   Duno, Morten ^b   Juncker, Inger ^c   Eiberg, Hans ^d   Vissing, John ^b   Bundgaard, Henning ^b   Wohlfahrt, Jan ^a   Melbye, Mads ^a,e  

^a STATENS SERUM INSTITUT   (Denmark)

^b Mental Health Center Glostrup   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac disease; Epidemiology; Myotonic dystrophy

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CHILD; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; HEART ARRHYTHMIA; HEART DISEASE; HEART FAILURE; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MYOTONIC DYSTROPHY; NEWBORN; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; STANDARDIZED INCIDENCE RATIO; COMPLICATION; CROSS-SECTIONAL STUDY; DENMARK; HEART DISEASES; INCIDENCE; MIDDLE AGED; PRESCHOOL CHILD; RISK FACTOR; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DENMARK; FEMALE; HEART DISEASES; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MYOTONIC DYSTROPHY; RISK FACTORS; YOUNG ADULT;

EID: 84904960351     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu157     Document Type: Article

References (18)

1. Turner C, Hilton-Jones D. The myotonic dystrophies: diagnosis and management. J Neurol Neurosurg Psychiatry 2010;81:358-367.
2. Udd B, Krahe R. The myotonic dystrophies: molecular, clinical, and therapeutic challenges. Lancet Neurol 2012;11:891-905.
3. Hermans MC, Pinto YM, Merkies IS, de Die-Smulders CE, Crijns HJ, Faber CG. Hereditary muscular dystrophies and the heart. Neuromuscul Disord 2010;20:479-492.
4. Schoser BG, Ricker K, Schneider-Gold C, Hengstenberg C, Durre J, Bultmann B, Kress W, Day JW, Ranum LP. Sudden cardiac death in myotonic dystrophy type 2. Neurology 2004;63:2402-2404.
5. Meola G, Sansone V, Marinou K, Cotelli M, Moxley RT III, Thornton CA, De AL. Proximal myotonic myopathy: a syndrome with a favourable prognosis? J Neurol Sci 2002;193:89-96.
6. Cudia P, Bernasconi P, Chiodelli R, Mangiola F, Bellocci F, Dello RA, Angelini C, Romeo V, Melacini P, Politano L, Palladino A, Nigro G, Siciliano G, Falorni M, Bongiorni MG, Falcone C, Mantegazza R, Morandi L. Risk of arrhythmia in type I myotonic dystrophy: the role of clinical and genetic variables. J Neurol Neurosurg Psychiatry 2009;80:790-793.
7. Petri H, Vissing J, Witting N, Bundgaard H, Kober L. Cardiac manifestations of myotonic dystrophy type 1. Int J Cardiol 2012;160:82-88.
8. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO. 2012 ACCF/ AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation 2013;127:e283-e352.
9. Groh WJ, Groh MR, Saha C, Kincaid JC, Simmons Z, Ciafaloni E, Pourmand R, Otten RF, Bhakta D, Nair GV, Marashdeh MM, Zipes DP, Pascuzzi RM. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med 2008;358:2688-2697.
10. Wahbi K, Meune C, Porcher R, Becane HM, Lazarus A, Laforet P, Stojkovic T, Behin A, Radvanyi-Hoffmann H, Eymard B, Duboc D. Electrophysiological study with prophylactic pacing and survival in adults with myotonic dystrophy and conduction system disease. JAMA 2012;307:1292-1301.
11. Pedersen CB. The Danish Civil Registration System. Scand J Public Health 2011;39(7 Suppl.):22-25.
12. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health 2011;39(7 Suppl.):30-33.
13. Kamsteeg EJ, Kress W, Catalli C, Hertz JM, Witsch-Baumgartner M, Buckley MF, van Engelen BG, Schwartz M, Scheffer H. Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2. Eur J Hum Genet 2012;20:1203-1208.
14. Greenland S, Rothmann KJ. Fundamentals of epidemiology data analysis. In: Rothmann KJ, Greenland S, Lash TL eds. Modern Epidemiology. Philadelphia, USA: Lippincott Williams and Wilkins; 2008. p. 213-237.
15. Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, Jansen G, Neville C, Narang M, Barcelo J, O'Hoy K, Leblond S, Earle-Macdonald J, De JP, Wieringa B, Korneluk RG. Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science 1992;255:1253-1255.
16. Fu YH, Pizzuti A, Fenwick RG Jr, King J, Rajnarayan S, Dunne PW, Dubel J, Nasser GA, Ashizawa T, de Jong P, Wieringa B, Korneluk R, Perryman MB, Epstein HF, Caskey CT. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992;255:1256-1258.
17. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, Hunter K, Stanton VP, Thirion JP, Hudson T, Sohn R, Zemelman B, Snell RG, Rundle SA, Crow S, Davies J, Shelbourne P, Buxton J, Jones C, Juvonen V, Johnson K, Harper PS, Shaw DJ, Housman DE. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 1992;69:385.
18. Heatwole CR, Statland JM, Logigian EL. The diagnosis and treatment of myotonic disorders. Muscle Nerve 2013;47:632-648.